Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity

被引:27
作者
Abuhammad, Areej [1 ,2 ,3 ]
Lowe, Edward D. [2 ]
McDonough, Michael A. [4 ]
Stewart, Patrick D. Shaw [5 ]
Kolek, Stefan A. [5 ]
Sim, Edith [1 ,6 ]
Garman, Elspeth F. [2 ]
机构
[1] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
[2] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England
[3] Univ Jordan, Fac Pharm, Amman 11942, Jordan
[4] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England
[5] Douglas Instruments, Hungerford RG17 7HD, Berks, England
[6] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2013年 / 69卷
关键词
CHOLESTEROL CATABOLISM; HYDROGEN-BONDS; DRUG; BINDING; STABILITY; GENOMICS; TB; CRYSTALLIZATION; IDENTIFICATION; INHIBITORS;
D O I
10.1107/S0907444913015126
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Arylamine N-acetyltransferase from Mycobacterium tuberculosis (TBNAT) plays an important role in the intracellular survival of the microorganism inside macrophages. Medicinal chemistry efforts to optimize inhibitors of the TBNAT enzyme have been hampered by the lack of a three-dimensional structure of the enzyme. In this paper, the first structure of TBNAT, determined using a lone crystal produced using cross-seeding with the homologous protein from M. marinum, is reported. Despite the similarity between the two enzymes (74% sequence identity), they show distinct physical and biochemical characteristics. The structure elegantly reveals the characteristic features of the protein surface as well as details of the active site of TBNAT relevant to drug-discovery efforts. The crystallographic analysis of the diffraction data presented many challenges, since the crystal was twinned and the habit possessed pseudo-translational symmetry.
引用
收藏
页码:1433 / 1446
页数:14
相关论文
共 92 条
[1]  
Abuhammad A., 2013, THESIS U OXFORD ENGL
[2]   Piperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside Macrophages [J].
Abuhammad, Areej ;
Fullam, Elizabeth ;
Lowe, Edward D. ;
Staunton, David ;
Kawamura, Akane ;
Westwood, Isaac M. ;
Bhakta, Sanjib ;
Garner, Alun Christopher ;
Wilson, David L. ;
Seden, Peter T. ;
Davies, Stephen G. ;
Russell, Angela J. ;
Garman, Elspeth F. ;
Sim, Edith .
PLOS ONE, 2012, 7 (12)
[3]   Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N-acetyltransferase (TBNAT) a potential target for novel anti-tubercular agents [J].
Abuhammad, Areej ;
Lack, Nathan ;
Schweichler, Judith ;
Staunton, David ;
Sim, Robert B. ;
Sim, Edith .
PROTEIN EXPRESSION AND PURIFICATION, 2011, 80 (02) :246-252
[4]   Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site [J].
Abuhammad, Areej M. ;
Lowe, Edward D. ;
Fullam, Elizabeth ;
Noble, Martin ;
Garman, Elspeth F. ;
Sim, Edith .
PROTEIN & CELL, 2010, 1 (04) :384-392
[5]  
Adamina M., 2007, INTERACTIONS LIPOSOM
[6]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[7]   The potential of azole antifungals against latent/persistent tuberculosis [J].
Ahmad, Z ;
Sharma, S ;
Khuller, GK .
FEMS MICROBIOLOGY LETTERS, 2006, 258 (02) :200-203
[8]   Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG [J].
Anderton, MC ;
Bhakta, S ;
Besra, GS ;
Jeavons, P ;
Eltis, LD ;
Sim, E .
MOLECULAR MICROBIOLOGY, 2006, 59 (01) :181-192
[9]   A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].
Andries, K ;
Verhasselt, P ;
Guillemont, J ;
Göhlmann, HWH ;
Neefs, JM ;
Winkler, H ;
Van Gestel, J ;
Timmerman, P ;
Zhu, M ;
Lee, E ;
Williams, P ;
de Chaffoy, D ;
Huitric, E ;
Hoffner, S ;
Cambau, E ;
Truffot-Pernot, C ;
Lounis, N ;
Jarlier, V .
SCIENCE, 2005, 307 (5707) :223-227
[10]   The potential impact of structural genomics on tuberculosis drug discovery [J].
Arcus, VL ;
Lott, JS ;
Johnston, JM ;
Baker, EN .
DRUG DISCOVERY TODAY, 2006, 11 (1-2) :28-34